Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4304600)

Published in J Blood Med on January 19, 2015

Authors

Augustine Ejike Okoye1, Obike Godswill Ibegbulam2, Robinson Chukwudi Onoh3, Ngozi Immaculata Ugwu1, Chukwudi Simon Anigbo2, Charles Emeka Nonyelu2

Author Affiliations

1: Department of Haematology and Immunology, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria.
2: Department of Haematology and Immunology, University of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla, Enugu State, Nigeria.
3: Department of Obstetrics and Gynaecology, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria.

Articles cited by this

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08

Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A (1983) 14.09

Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood (1977) 10.69

HTLV-I screening in Britain. BMJ (1995) 2.25

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology (2005) 1.86

Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS (1993) 1.32

Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev (1997) 1.22

Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia (1997) 1.22

Prevalence of antibody to human T cell leukaemia/lymphoma virus in women attending antenatal clinic in southeast London: retrospective study. BMJ (2000) 1.12

New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa. J Clin Microbiol (2008) 0.95

Clinical impact of HTLV-1 infection in Spain: implications for public health and mandatory screening. J Acquir Immune Defic Syndr (2002) 0.93

Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria. Cent Afr J Med (1998) 0.92

Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model. Int J Epidemiol (2000) 0.92

Human T-cell lymphotropic virus in a population of pregnant women and commercial sex workers in South Western Nigeria. Afr Health Sci (2007) 0.90

Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology. Cad Saude Publica (2003) 0.90

Antibodies to ATLV (HTLV) in Nigerian blood donors and patients with chronic lymphatic leukaemia or lymphoma. Lancet (1983) 0.88

A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27. Hum Mol Genet (2006) 0.86

Human T-cell leukaemia virus in Africa: possible roles in health and disease. IARC Sci Publ (1984) 0.79

Epidemiology of HTLV-I infection in Spain. HTLV Spanish Study Group. Int J Epidemiol (1996) 0.78